Hematology NewsCLL drug combinations induce MRD negativityDecember 11, 2017CLLLymphoma & Plasma Cell Disorders
Hematology NewsCLARITY: Ibrutinib/venetoclax combo results look promising for relapsed/refractory CLLDecember 10, 2017CLLLeukemia, Myelodysplasia, Transplantation
Oncology PracticeLate-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017ThrombosisCLLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology NewsStudies need to address best follow-on therapy to ibrutinib in CLLNovember 18, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIdelalisib efficacy against CLL tarnished by toxicityOctober 28, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsDeep remission or long-term control? Choice is key in early CLLOctober 27, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsM13-982 trial in del(17p) CLL: High, durable response rates to venetoclaxJuly 26, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsIbrutinib and bleeding complications in Mohs surgeryJuly 20, 2017CLLNonmelanoma Skin Cancer
Hematology NewsFirst-line obinutuzumab monotherapy in CLL linked to good response, reduced toxicityJuly 13, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsNF-kB inhibitor IT-901 shows promise in Richter syndromeJuly 5, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsTelomere length predicts FCR response in CLL patientsJuly 5, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsOptimizing therapy in relapsed CLL: ibrutinib and beyondJune 23, 2017CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsTwofer drug blocks SYK/JAK pathways in advanced NHLJune 23, 2017CLLLymphoma & Plasma Cell DisordersAggressive LymphomasFollicular Lymphoma
Hematology NewsFDA approves rituximab + hyaluronidase human for FL, DLBCL, and CLLJune 22, 2017CLLAggressive LymphomasLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsLenalidomide consolidation linked to extended overall survival in non-del(11q) CLLJune 22, 2017CLLLeukemia, Myelodysplasia, Transplantation
